313 related articles for article (PubMed ID: 16141000)
1. Hypofibrinogenaemia caused by a novel FGG missense mutation (W253C) in the gamma chain globular domain impairing fibrinogen secretion.
Vu D; de Moerloose P; Batorova A; Lazur J; Palumbo L; Neerman-Arbez M
J Med Genet; 2005 Sep; 42(9):e57. PubMed ID: 16141000
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations.
Neerman-Arbez M; de Moerloose P
Hum Mutat; 2007 Jun; 28(6):540-53. PubMed ID: 17295221
[TBL] [Abstract][Full Text] [Related]
3. Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion.
Vu D; Bolton-Maggs PH; Parr JR; Morris MA; de Moerloose P; Neerman-Arbez M
Blood; 2003 Dec; 102(13):4413-5. PubMed ID: 12893758
[TBL] [Abstract][Full Text] [Related]
4. Congenital hypofibrinogenemia: characterization of two missense mutations affecting fibrinogen assembly and secretion.
Platè M; Asselta R; Spena S; Spreafico M; Fagoonee S; Peyvandi F; Tenchini ML; Duga S
Blood Cells Mol Dis; 2008; 41(3):292-7. PubMed ID: 18676163
[TBL] [Abstract][Full Text] [Related]
5. Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency.
Asselta R; Platè M; Robusto M; Borhany M; Guella I; Soldà G; Afrasiabi A; Menegatti M; Shamsi T; Peyvandi F; Duga S
Thromb Haemost; 2015 Mar; 113(3):567-76. PubMed ID: 25427968
[TBL] [Abstract][Full Text] [Related]
6. Quality control of fibrinogen secretion in the molecular pathogenesis of congenital afibrinogenemia.
Vu D; Di Sanza C; Caille D; de Moerloose P; Scheib H; Meda P; Neerman-Arbez M
Hum Mol Genet; 2005 Nov; 14(21):3271-80. PubMed ID: 16195396
[TBL] [Abstract][Full Text] [Related]
7. A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia.
Fujihara N; Haneishi A; Yamauchi K; Terasawa F; Ito T; Ishida F; Okumura N
Thromb Haemost; 2010 Aug; 104(2):213-23. PubMed ID: 20589319
[TBL] [Abstract][Full Text] [Related]
8. Manipulating the quality control pathway in transfected cells: low temperature allows rescue of secretion-defective fibrinogen mutants.
Vu D; Di Sanza C; Neerman-Arbez M
Haematologica; 2008 Feb; 93(2):224-31. PubMed ID: 18223281
[TBL] [Abstract][Full Text] [Related]
9. Identification and functional characterization of a novel nonsense mutation in FGA accounting for congenital afibrinogenemia in six Egyptian patients.
Abdel Wahab M; de Moerloose P; Fish RJ; Neerman-Arbez M
Blood Coagul Fibrinolysis; 2010 Mar; 21(2):164-7. PubMed ID: 20051841
[TBL] [Abstract][Full Text] [Related]
10. Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob 'A'.
Vorjohann S; Fish RJ; Biron-Andréani C; Nagaswami C; Weisel JW; Boulot P; Reyftmann L; de Moerloose P; Neerman-Arbez M
Thromb Haemost; 2010 Nov; 104(5):990-7. PubMed ID: 20806111
[TBL] [Abstract][Full Text] [Related]
11. A novel fibrinogen B beta chain frameshift mutation causes congenital afibrinogenaemia.
Zhang J; Zhao X; Wang Z; Yu Z; Cao L; Zhang W; Bai X; Ruan C
Thromb Haemost; 2013 Jul; 110(1):76-82. PubMed ID: 23740095
[TBL] [Abstract][Full Text] [Related]
12. A novel fibrinogen Bbeta chain frameshift mutation in a patient with severe congenital hypofibrinogenaemia.
Xu X; Wu J; Zhai Z; Zhou R; Wang X; Wang H; Ding K; Sun Z; Ni H
Thromb Haemost; 2006 Jun; 95(6):931-5. PubMed ID: 16732370
[TBL] [Abstract][Full Text] [Related]
13. Pseudo-exon activation caused by a deep-intronic mutation in the fibrinogen gamma-chain gene as a novel mechanism for congenital afibrinogenaemia.
Spena S; Asselta R; Platé M; Castaman G; Duga S; Tenchini ML
Br J Haematol; 2007 Oct; 139(1):128-32. PubMed ID: 17854317
[TBL] [Abstract][Full Text] [Related]
14. Expression of four mutant fibrinogen gammaC domains in Pichia pastoris confirms them as causes of hypofibrinogenaemia.
Sheen CR; Dear A; Brennan SO
Protein Expr Purif; 2010 Oct; 73(2):184-8. PubMed ID: 20580674
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation.
Asselta R; Robusto M; Platé M; Santoro C; Peyvandi F; Duga S
Thromb Res; 2015 Jul; 136(1):168-74. PubMed ID: 26006300
[TBL] [Abstract][Full Text] [Related]
16. Protein modelling to understand FGB mutations leading to congenital hypofibrinogenaemia.
Casini A; Vilar R; Beauverd Y; Aslan D; Devreese K; Mondelaers V; Alberio L; Gubert C; de Moerloose P; Neerman-Arbez M
Haemophilia; 2017 Jul; 23(4):583-589. PubMed ID: 28306188
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bbeta-chain gene causing afibrinogenemia.
Asselta R; Spena S; Duga S; Peyvandi F; Malcovati M; Mannucci PM; Tenchini ML
Haematologica; 2002 Aug; 87(8):855-9. PubMed ID: 12161363
[TBL] [Abstract][Full Text] [Related]
18. Identification of three FGA mutations in two Chinese families with congenital afibrinogenaemia.
Fang Y; Dai BT; Wang XF; Fu QH; Dai J; Xie F; Cai XH; Wang HL; Wang ZY
Haemophilia; 2006 Nov; 12(6):615-20. PubMed ID: 17083511
[TBL] [Abstract][Full Text] [Related]
19. The molecular mechanisms of congenital hypofibrinogenaemia.
Maghzal GJ; Brennan SO; Homer VM; George PM
Cell Mol Life Sci; 2004 Jun; 61(12):1427-38. PubMed ID: 15197468
[TBL] [Abstract][Full Text] [Related]
20. Mutational screening of six afibrinogenemic patients: identification and characterization of four novel molecular defects.
Monaldini L; Asselta R; Duga S; Peyvandi F; Karimi M; Malcovati M; Tenchini ML
Thromb Haemost; 2007 Apr; 97(4):546-51. PubMed ID: 17393016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
